Subconjunctival and/or intrastromal bevacizumab injections as preconditioning therapy to promote corneal graft survival

[1]  B. Acar,et al.  The effect of different doses of subconjunctival bevacizumab injection on corneal neovascularization , 2013, International Ophthalmology.

[2]  S. Tuft,et al.  Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial , 2012, British Journal of Ophthalmology.

[3]  D. Azar,et al.  Corneal neovascularization: an anti-VEGF therapy review. , 2012, Survey of ophthalmology.

[4]  R. Forte,et al.  Effects of subconjunctival bevacizumab on corneal neovascularization: results of a prospective study , 2012, Cornea.

[5]  G. Foulks,et al.  Confocal Microscopy of Central Toxic Keratopathy , 2012, Cornea.

[6]  R. Dana,et al.  Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). , 2012, The ocular surface.

[7]  E. Balestrazzi,et al.  Graft Rejection After Femtosecond Laser–Assisted Deep Anterior Lamellar Keratoplasty: Report of 3 Cases , 2011, Cornea.

[8]  C. McGhee,et al.  The New Zealand National Eye Bank: Survival and Visual Outcome 1 Year After Penetrating Keratoplasty , 2011, Cornea.

[9]  G. Alessio,et al.  Excimer laser-assisted lamellar keratoplasty and the corneal endothelium. , 2010, American journal of ophthalmology.

[10]  Richard J. Symes,et al.  Corneal Graft Surgery Combined with Subconjunctival Bevacizumab (Avastin) , 2010, Cornea.

[11]  R. Dana,et al.  Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival. , 2010, Investigative ophthalmology & visual science.

[12]  P. Vassileva,et al.  Avastin use in high risk corneal transplantation , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.

[13]  U. Pleyer,et al.  The taming of the shrew? The immunology of corneal transplantation , 2009, Acta ophthalmologica.

[14]  M. Dana,et al.  Corneal Graft Rejection , 2009, International ophthalmology clinics.

[15]  Ahmed Awadein.  Subconjunctival bevacizumab for vascularized rejected corneal grafts. , 2007, Journal of cataract and refractive surgery.

[16]  C. McGhee,et al.  In Vivo Confocal Microscopy of Subepithelial Infiltrates in Human Corneal Transplant Rejection , 2007, Cornea.

[17]  J. Niederkorn.  Immune Mechanisms of Corneal Allograft Rejection , 2007, Current eye research.

[18]  J. Palmblad,et al.  Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing. , 2004, Acta ophthalmologica Scandinavica.

[19]  Jingtai Cao,et al.  VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. , 2004, The Journal of clinical investigation.

[20]  S. Seregard,et al.  Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization. , 2000, Experimental eye research.

[21]  B. Kirchhof,et al.  Topical application of methotrexate for inhibition of corneal angiogenesis , 1999, Graefe's Archive for Clinical and Experimental Ophthalmology.

[22]  Y. Wen,et al.  Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea. , 1999, Investigative ophthalmology & visual science.

[23]  G. Naumann,et al.  Angiogenesis in corneal diseases: histopathologic evaluation of 254 human corneal buttons with neovascularization. , 1998, Cornea.

[24]  A. Adamis,et al.  Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. , 1998, Investigative ophthalmology & visual science.

[25]  R. D'Amato,et al.  Thalidomide is an inhibitor of angiogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Hendricks,et al.  Suppression of corneal neovascularization with cyclosporine. , 1992, Archives of ophthalmology.

[27]  G. Breier,et al.  Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. , 1992, Development.

[28]  H. Phillips,et al.  Molecular Characterization and Distribution of Vascular Endothelial Growth Factor , 1991 .